AMDI Introduces the Autolab™ HBH System
Autonomous Medical Devices Incorporated (AMDI) is making significant strides in the field of molecular diagnostics with its latest innovation, the Autolab™ HBH system. This new technology was launched at the ESCMID Global Congress 2025, where it has drawn considerable interest from attendees and experts alike. The Autolab™ HBH system promises to redefine sample preparation, streamlining workflows across various research and diagnostic applications.
Innovative Technology in Action
The Autolab™ HBH system leverages AMDI's cutting-edge Hyperbaric Heating (HBH) technology, facilitating rapid sample lysis and nucleic acid access. Traditional extraction methods can often be tedious, requiring lengthy processing times and complex procedures. In contrast, the Autolab™ HBH can process samples in under two minutes, offering an efficient alternative that saves time and resources for laboratories.
Commitment to Improving Molecular Workflows
David Okrongly, CEO of AMDI, emphasized the company's commitment to overcoming long-standing challenges in the molecular testing landscape. According to him, "The Autolab™ HBH system was developed to tackle issues related to complexity, time, and cost within sample preparation." This launch aligns with AMDI's broader mission: to create advanced laboratory tools that enhance molecular testing accessibility and quality, whether for PCR analysis, sequencing, or other applications.
Versatility Across Applications
One of the notable advantages of the Autolab™ HBH is its ability to support diverse sample matrices. This versatility makes it a valuable tool not just for clinical research but also for public health initiatives and environmental monitoring. As researchers and institutions seek more reliable and faster diagnostic options, products like the Autolab™ HBH are positioned to meet those demands effectively.
Live Demonstrations at ESCMID 2025
During the ESCMID 2025 conference, attendees have the opportunity to see live demonstrations of the Autolab™ HBH system at Booth #D760. This hands-on experience allows visitors to better understand the capabilities and benefits of this revolutionary technology, as well as the potential it has to reshape molecular workflows.
About AMDI
Autonomous Medical Devices Incorporated (AMDI) is a California-based company focused on developing next-generation diagnostics. Their innovative solutions aim to enhance testing speed, accuracy, and accessibility. AMDI's products are produced in an ISO 13485-certified facility located in Santa Ana, CA, ensuring the highest standards of quality in their offerings.
Media Inquiries
For further information or media inquiries, please contact Brian Miller. AMDI is committed to transparency and communication as they drive advancements in molecular diagnostics.
Frequently Asked Questions
What is the Autolab™ HBH system?
The Autolab™ HBH system is a revolutionary technology developed by AMDI for fast and efficient nucleic acid sample preparation.
How does the HBH technology work?
The Hyperbaric Heating technology rapidly lyses samples, drastically reducing the time needed for nucleic acid extraction compared to conventional methods.
In what settings can the Autolab™ HBH be used?
The system is versatile and applicable in clinical research, public health, and environmental monitoring among other fields.
Where can I see the Autolab™ HBH in action?
Live demonstrations are available at the ESCMID 2025 conference at Booth #D760.
What is AMDI's mission?
AMDI aims to improve molecular testing efficiency, access, and accuracy through their innovative diagnostic solutions.
